Role of Ventral Pallidum Projection to VTA in Reinstatement of Cocaine Seeking

腹侧苍白球投射至 VTA 在恢复可卡因寻求中的作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): Addiction is a major health concern, and its chronic relapsing nature is perhaps its most insidious aspect. Exposure to drug-associated cues is a risk factor for relapse, and understanding how the brain processes these cues may lead to addiction therapies. Here, I examine the role of projections from the ventral palladium (VP) to ventral tegmental area (VTA) in a rat self-administration/cue-induced reinstatement model of relapse. I will employ novel, viral-based means of controlling this pathway, including designer receptors (DREADDs) that inhibit neuronal activity when an otherwise inert drug (CNO) is administered, and opsins, which allow control of neuronal activity with light. I have found that projections from the rostral portion of VP (RVP) to VTA are activated during cued reinstatement, and that DREADD-based inactivation of RVP and its VTA projections specifically block this behavior. Here, I explore the mechanisms by which RVP-VTA projections mediate cued reinstatement, and how RVP inputs modulate VTA activity. In the K99 Aims, I propose confirming and extending my findings that inhibiting RVP projections to VTA in particular with DREADDs specifically blocks cued reinstatement. Next, I propose electrophysiologically examining how RVP inputs to VTA modulate firing of VTA dopamine and non-dopamine neurons, and how inhibiting this pathway affects VTA neuronal activity. With the training in electrophysiology and opto/pharmacogenetic modulation of brain circuits I receive during the K99 period, I will employ these techniques to further determine the functional roles of the RVP-VTA circuit in cued reinstatement during the R00 period. First, I will determine whether RVP projections to VTA require dopamine in order to have effects on reinstatement behavior, using a transgenic rat line allowing expression of DREADDs specifically in dopamine neurons. Next, I will examine the temporal relationship of RVP-VTA projection activity to transient cue presentations in the reinstatement context using inhibitory optogenetic techniques. I will determine whether phasic, cue-locked activation or tonic activation of RVP inputs is necessary for conditioned stimuli to elicit reinstatement. These experiments will therefore characterize the mechanisms of the novel, functionally-identified RVP-VTA pathway, which is crucially involved in cue-induced reinstatement of cocaine seeking in a rat model of relapse in addiction.
描述(由申请人提供):成瘾是一个主要的健康问题,其慢性复发的性质可能是其最阴险的方面。暴露于药物相关的线索是复发的风险因素,了解大脑如何处理这些线索可能会导致成瘾治疗。在这里,我研究的作用,从腹侧钯(VP)腹侧被盖区(VTA)在大鼠自我管理/线索诱导的复发模型的预测。我将采用新的,基于病毒的手段来控制这一途径,包括设计受体(DREADDs),当给予惰性药物(CNO)时,它会抑制神经元的活动,以及视蛋白,它允许用光来控制神经元的活动。我发现, VP(RVP)至VTA吻侧部分在线索恢复期间被激活,且RVP及其VTA投射的基于DREADD的失活特异性地阻断该行为。在这里,我探讨的机制,RVP-VTA预测调解线索恢复,以及如何RVP输入调制VTA活动。 在K99目标中,我建议确认和扩展我的发现,即抑制RVP投射到VTA,特别是DREADD,特别会阻止线索恢复。接下来,我建议电生理研究如何RVP输入腹侧被盖区调制放电腹侧被盖区多巴胺和非多巴胺神经元,以及如何抑制这一途径影响腹侧被盖区神经元的活动。 随着我在K99期间接受的脑回路电生理学和光学/药物遗传学调制的培训,我将采用这些技术来进一步确定R 00期间RVP-VTA回路在线索恢复中的功能作用。首先,我将确定是否RVP预测腹侧被盖区需要多巴胺,以恢复行为的影响,使用转基因大鼠行允许表达的DREADDs,特别是在多巴胺神经元。接下来,我将使用抑制性光遗传学技术来检查RVP-VTA投射活动与恢复背景下的瞬时线索呈现的时间关系。我将确定是否相位,线索锁定激活或紧张性激活的RVP输入是必要的条件刺激,以引起恢复。因此,这些实验将表征新的功能鉴定的RVP-VTA途径的机制,其在成瘾复发的大鼠模型中关键地参与可卡因寻求的线索诱导的恢复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen Vincent Mahler其他文献

Stephen Vincent Mahler的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen Vincent Mahler', 18)}}的其他基金

Ventral Pallidum Circuits Underlying Preclinical Models of Opioid Addiction
阿片类药物成瘾临床前模型的腹侧苍白球回路
  • 批准号:
    10587642
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
ICAL: Impact of Cannabinoids Across Lifespan: Animal Core
ICAL:大麻素对整个生命周期的影响:动物核心
  • 批准号:
    10188475
  • 财政年份:
    2018
  • 资助金额:
    $ 12.01万
  • 项目类别:
ICAL: Impact of Cannabinoids Across Lifespan: Behavioral Project
ICAL:大麻素对整个生命周期的影响:行为项目
  • 批准号:
    10188480
  • 财政年份:
    2018
  • 资助金额:
    $ 12.01万
  • 项目类别:
Role of Ventral Pallidum Projection to VTA in Reinstatement of Cocaine Seeking
腹侧苍白球投射至 VTA 在恢复可卡因寻求中的作用
  • 批准号:
    9479923
  • 财政年份:
    2015
  • 资助金额:
    $ 12.01万
  • 项目类别:
Role of Ventral Pallidum Projection to VTA in Reinstatement of Cocaine Seeking
腹侧苍白球投射至 VTA 在恢复可卡因寻求中的作用
  • 批准号:
    8990066
  • 财政年份:
    2015
  • 资助金额:
    $ 12.01万
  • 项目类别:
VTA Glutamate and Orexin Involvement in Cue Reinstatement of Drug Seeking
VTA 谷氨酸和食欲素参与药物寻求提示的恢复
  • 批准号:
    8214611
  • 财政年份:
    2010
  • 资助金额:
    $ 12.01万
  • 项目类别:
VTA Glutamate and Orexin Involvement in Cue Reinstatement of Drug Seeking
VTA 谷氨酸和食欲素参与药物寻求提示的恢复
  • 批准号:
    7805892
  • 财政年份:
    2010
  • 资助金额:
    $ 12.01万
  • 项目类别:
VTA Glutamate and Orexin Involvement in Cue Reinstatement of Drug Seeking
VTA 谷氨酸和食欲素参与药物寻求提示的恢复
  • 批准号:
    8019989
  • 财政年份:
    2010
  • 资助金额:
    $ 12.01万
  • 项目类别:
Opioid Modulation of Cue-Triggered 'Wanting' in Amygdala
阿片类药物对杏仁核中提示触发的“想要”的调节
  • 批准号:
    7496517
  • 财政年份:
    2006
  • 资助金额:
    $ 12.01万
  • 项目类别:
Opioid Modulation of Cue-Triggered 'Wanting' in Amygdala
阿片类药物对杏仁核中提示触发的“想要”的调节
  • 批准号:
    7298601
  • 财政年份:
    2006
  • 资助金额:
    $ 12.01万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
  • 批准号:
    23K05057
  • 财政年份:
    2023
  • 资助金额:
    $ 12.01万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了